CCN2 and breast cancer: Interestingly, CTGF knockdown in HG cells (CTGFsiRNA cells; Figure 3A and Supplementary Figure 1C) significantly increased BC cell sensitivity to tamoxifen (≈40% cell viability; p<0.001; Figure 3B).